Marker Therapeutics, Inc.
MRKR
$1.42
-$0.04-2.74%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.07M | 17.59M | 10.46M | 13.69M | 19.19M |
| Total Receivables | 1.37M | 1.67M | 1.67M | 2.46M | 2.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 658.80K | 1.13M | 1.28M | 841.30K | 483.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 974.80K | 1.35M | 1.35M | -- | -- |
| Total Current Assets | 19.07M | 21.73M | 14.77M | 16.99M | 22.02M |
|
|
|||||
| Total Current Assets | 19.07M | 21.73M | 14.77M | 16.99M | 22.02M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 19.07M | 21.73M | 14.77M | 16.99M | 22.02M |
|
|
|||||
| Total Accounts Payable | 793.70K | 1.66M | 2.27M | 1.30M | 1.07M |
| Total Accrued Expenses | 301.70K | 328.30K | 656.60K | 1.00M | 2.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.18M | 1.35M | 1.35M | 204.00K | 203.40K |
| Total Other Current Liabilities | 1.18M | 1.35M | 1.35M | 204.00K | 203.40K |
| Total Current Liabilities | 2.27M | 3.35M | 4.28M | 2.50M | 3.46M |
|
|
|||||
| Total Current Liabilities | 2.27M | 3.35M | 4.28M | 2.50M | 3.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.27M | 3.35M | 4.28M | 2.50M | 3.46M |
|
|
|||||
| Common Stock & APIC | 475.98M | 475.87M | 465.97M | 465.96M | 465.58M |
| Retained Earnings | -459.18M | -457.48M | -455.48M | -451.46M | -447.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 16.80M | 18.39M | 10.49M | 14.49M | 18.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.80M | 18.39M | 10.49M | 14.49M | 18.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.80M | 18.39M | 10.49M | 14.49M | 18.56M |
|
|
|||||